Papadimos Thomas J, Soghoian Samara E, Nanayakkara Prabath, Singh Sarman, Miller Andrew C, Saddikuti Venkataramanaiah, Jayatilleke Achala Upendra, Dubhashi Siddharth P, Firstenberg Michael S, Dutta Vibha, Chauhan Vivek, Sharma Pushpa, Galwankar Sagar C, Garg Manish, Taylor Nicholas, Stawicki Stanislaw P
On Behalf of the Multidisciplinary ACAIM-WACEM COVID-19 Consensus Group, Bethlehem, PA, USA.
J Glob Infect Dis. 2020 Nov 30;12(4):167-190. doi: 10.4103/jgid.jgid_397_20. eCollection 2020 Oct-Dec.
As the COVID-19 pandemic continues, important discoveries and considerations emerge regarding the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathogen; its biological and epidemiological characteristics; and the corresponding psychological, societal, and public health (PH) impacts. During the past year, the global community underwent a massive transformation, including the implementation of numerous nonpharmacological interventions; critical diversions or modifications across various spheres of our economic and public domains; and a transition from consumption-driven to conservation-based behaviors. Providing essential necessities such as food, water, health care, financial, and other services has become a formidable challenge, with significant threats to the existing supply chains and the shortage or reduction of workforce across many sectors of the global economy. Food and pharmaceutical supply chains constitute uniquely vulnerable and critically important areas that require high levels of safety and compliance. Many regional health-care systems faced at least one wave of overwhelming COVID-19 case surges, and still face the possibility of a new wave of infections on the horizon, potentially in combination with other endemic diseases such as influenza, dengue, tuberculosis, and malaria. In this context, the need for an effective and scientifically informed leadership to sustain and improve global capacity to ensure international health security is starkly apparent. Public health "blind spotting," promulgation of pseudoscience, and academic dishonesty emerged as significant threats to population health and stability during the pandemic. The goal of this consensus statement is to provide a focused summary of such "blind spots" identified during an expert group intense analysis of "missed opportunities" during the initial wave of the pandemic.
随着新冠疫情持续,关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病原体、其生物学和流行病学特征以及相应的心理、社会和公共卫生影响,出现了重要的发现和思考。在过去一年里,全球社会经历了巨大变革,包括实施了众多非药物干预措施;经济和公共领域各个方面出现了重大转向或调整;以及从消费驱动型行为向基于节约的行为转变。提供食品、水、医疗保健、金融和其他服务等基本必需品已成为一项艰巨挑战,对现有供应链构成重大威胁,全球经济许多部门的劳动力短缺或减少。食品和药品供应链是特别脆弱且至关重要的领域,需要高度的安全性和合规性。许多地区医疗系统至少经历了一波新冠病例激增,而且仍面临新一波感染的可能性,这可能与流感、登革热、结核病和疟疾等其他地方病同时出现。在这种背景下,显然迫切需要有成效且基于科学的领导力来维持和提高全球确保国际卫生安全的能力。在疫情期间,公共卫生“盲点”、伪科学的传播以及学术不诚实行为成为对民众健康和稳定的重大威胁。本共识声明的目的是重点总结在专家组对疫情第一波期间“错失的机会”进行深入分析过程中所确定的此类“盲点”。